Is triamcinolone acetonide useful and safe in meralgia paresthetica? Randomized control trial
- Conditions
- Health Condition 1: null- Meralgia ParestheticaHealth Condition 2: G571- Meralgia paresthetica
- Registration Number
- CTRI/2017/10/010000
- Lead Sponsor
- Delhi Neurological Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients in age group 18-80 years with spontaneous meralgia paresthetica (not related to surgical procedures in the region of the anterior superior iliac spine such as osteotomy for bone grafting, spinal surgeries etc).
2.Meralgia paresthetica is a clinical diagnosis: Patients have unpleasant paresthesias tingling or burning over the lateral aspect of the upper half to upper 2/3 of the thigh. It may be bilateral in 20% of cases.
•Subjects not giving consent
•Meralgia paresthetica following surgical procedures on the iliac crest or the spine
•Patients who have previously undergone surgical procedures to relieve pain such as transposition, separation from muscular entrapment etc.
•Pregnant females
•Females in reproductive age group, who are not using adequate contraception.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study change in severity pain on a VAS scale from 0-10 in patients with meralgia paresthetica before and after injection of 40 mg of triamcinolone acetonide as compared to placebo injections.Timepoint: 2 weeks, 4 weeks
- Secondary Outcome Measures
Name Time Method 1.Onset of pain relief (days) <br/ ><br>2.percentage of patients who had complete relief <br/ ><br>3.Duration of pain relief (days/weeks) <br/ ><br>4.proportion of patients who are responders (atleast 50% reduction in VAS Score) and <br/ ><br>5.reduction in dosage of drugs used in pain relief of meralgia paresthetica in patients who undergo 40 mg triamcinolone acetonide injection in comparison with placebo <br/ ><br>6.Adverse effects of triamcinolone injectionsTimepoint: 2 weeks, 4 weeks